Literature DB >> 3702916

Prediction of familial predisposition to retinoblastoma.

W K Cavenee, A L Murphree, M M Shull, W F Benedict, R S Sparkes, E Kock, M Nordenskjold.   

Abstract

Retinoblastoma is a childhood cancer, predisposition to which is inherited as an autosomal dominant trait. We used restriction-fragment-length and isozymic alleles of loci on chromosome 13 in five families predisposed to retinoblastoma, to provide identification before illness of persons likely to have tumors. The likelihood of disease was predicted in two cases, and freedom from disease in three. The calculated predictive accuracy was greater than 94 percent in cases with informative loci flanking the retinoblastoma (RB1) locus, and our prediction has been fulfilled in each such instance. A case that was informative at several loci indicated the occurrence of meiotic recombination, and accurate prediction was based on data obtained with DNA markers and isozymic forms of esterase D. The calculated predictive accuracy in another case, which was informative only for loci distal to the retinoblastoma locus, was about 70 percent. This patient was expected to acquire the disease but had not done so at the age of one year, illustrating the need for more markers that are also more informative and genetically closer to the retinoblastoma locus. These studies provide the basis for prenatal and postnatal prediction of susceptibility to inherited cancer using arbitrary recombinant DNA markers. Such predictions should make genetic counseling for familial retinoblastoma more accurate and lead to earlier tumor detection and more effective therapy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3702916     DOI: 10.1056/NEJM198605083141901

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  25 in total

Review 1.  Gene mapping of mineral metabolic disorders.

Authors:  R V Thakker; K E Davies; J L O'Riordan
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

2.  Defining DNA diagnostic tests appropriate or standard clinical care.

Authors:  R V Lebo; G Cunningham; M J Simons; L J Shapiro
Journal:  Am J Hum Genet       Date:  1990-09       Impact factor: 11.025

3.  Application of intragenic DNA probes in prenatal screening for retinoblastoma gene carriers in the United Kingdom.

Authors:  Z O Onadim; C D Mitchell; P C Rutland; B G Buckle; M Jay; J L Hungerford; K Harper; J K Cowell
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

4.  Constitutional deletions predisposing to retinoblastoma.

Authors:  M Janson; E Kock; M Nordenskjöld
Journal:  Hum Genet       Date:  1990-06       Impact factor: 4.132

Review 5.  Secondary malignancies across the age spectrum.

Authors:  Andrea K Ng; Lisa B Kenney; Ethel S Gilbert; Lois B Travis
Journal:  Semin Radiat Oncol       Date:  2010-01       Impact factor: 5.934

Review 6.  The diagnosis of retinoblastoma.

Authors:  D H Abramson
Journal:  Bull N Y Acad Med       Date:  1988-05

7.  Parental origin of germ-line and somatic mutations in the retinoblastoma gene.

Authors:  M V Kato; K Ishizaki; T Shimizu; Y Ejima; H Tanooka; J Takayama; A Kaneko; J Toguchida; M S Sasaki
Journal:  Hum Genet       Date:  1994-07       Impact factor: 4.132

8.  The genetics of retinoblastoma, revisited.

Authors:  A Naumova; C Sapienza
Journal:  Am J Hum Genet       Date:  1994-02       Impact factor: 11.025

9.  Concordance between parental origin of chromosome 13q loss and chromosome 6p duplication in sporadic retinoblastoma.

Authors:  A Naumova; M Hansen; L Strong; P A Jones; D Hadjistilianou; D Mastrangelo; S Griegel; M F Rajewsky; J Shields; L Donoso
Journal:  Am J Hum Genet       Date:  1994-02       Impact factor: 11.025

10.  Oncogenetics. A new emerging field of cancer.

Authors:  R S Verma
Journal:  Mol Gen Genet       Date:  1986-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.